neutral
Recently
Nephro Health IPO sees muted demand on second day of bidding
Nephro Health’s IPO continued to see weak demand on Day 2, with limited subscription across categories despite a modest grey market premium.
Investor response to Nephro Health’s mainboard IPO remained subdued on Day 2, with overall subscription reaching just 0.32 times. Retail investors subscribed 0.39 times, QIBs 0.30 times, and NIIs 0.17 times, while the employee quota was nearly fully subscribed. The IPO closes on December 12. Grey market premium stands at Rs 20, implying a potential listing near Rs 480, around 4.3% above the issue price of Rs 460.